To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
The novel EBS therapy is a non-invasive and individually tailored to the patient stimulation method. The aim of the treatment is the improvement of vision by stimulating nerve cells with the help of weak current pulses."The effectiveness of the therapy has already been demonstrated in neurology, and we know that the principle works, and we are transferring this experience to the field of ophthalmology, a great advantage for patients being that the therapy is not painful and has no side effects appeared."Prof. Dr. med. Carl Erb, glaucoma expert and medical director of the Eye Clinic at Wittenbergplatz, Berlin
- 1Intas Biopharmaceuticals Ltd.
- 2LPT - Laboratory of Pharmacology and Toxicology GmbH & Co. KG
- 3Ranbaxy Laboratories Ltd.
- 4Life Technologies Corporation
- 5Scientis Pharma SA
- 6MEDICE Arzneimittel Pütter GmbH & Co. KG
- 7Sanofi-Aventis Deutschland GmbH
- 8TranScrip Partners
- 9BIOTON S.A.
- 10Abbott GmbH & Co. KG